Skip to content
2000
Volume 26, Issue 21
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background: In the pharmaceutical field, it is vital to ensure a consistent product containing a single solid-state form of the active pharmaceutical ingredient (API) in the drug product. However, some APIs are suffering from the risk of transformation of their target forms during processing, formulation and storage. Methods: The purpose of this review is to summarize the relevant category of excipients and demonstrate the availability and importance of using excipients as a key strategy to manipulate pharmaceutical polymorphic transformation. Results: The excipient effects on solvent-mediated phase transformations, solid-state transitions and amorphous crystallization are significant. Common pharmaceutical excipients including amino acids and derivatives, surfactants, and various polymers and their different manipulation effects were summarized and discussed. Conclusion: Appropriate use of excipients plays a role in manipulating polymorphic transformation process of corresponding APIs, with a promising application of guaranteeing the stability and effectiveness of drug dosage forms.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666200213122302
2020-06-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666200213122302
Loading

  • Article Type:
    Review Article
Keyword(s): amorphous; APIs; excipients; Manipulation; polymorphic transformation; stability
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test